glp 1 headache Headaches are one of the more common complaints I hear from patients on GLP- medications. And in many cases the cause is not the medication itself. It is under-fueling. GLP-1 therapies significantly GLP-1 reduces migraines and joint
Description
Both sides are marshaling their scientific evidence
The fast delivery promise is appealing, but speed of fulfillment matters little if the overall patient experience is inconsistent
Although a substantial amount of knowledge has been generated regarding the mechanism of action of both drug classes, much remains to be understood
By contrast, Wegovy sales in China are projected to reach 2.2 billion Danish crowns ($346 million) in 2025, with growth expected into 2026 before tapering as generics become available
New England Journal of Medicine, 387, 205216
F.JohnsonE
